Catastrophic expenditure to pay for surgery worldwide: a modelling study.
Catastrophic expenditure to pay for surgery worldwide: a modelling study.
复制标题
全球手术费用的灾难性支出:一项建模研究。
DOI:
10.1016/s2214-109x(15)70085-9
复制
发表时间:
2015-04-27
影响因子:
34.3
通讯作者:
Meara, John G.
中科院分区:
文献类型:
--
作者:
Shrime, Mark G.;Dare, Anna J.;Alkire, Blake C.;O'Neill, Kathleen;Meara, John G.
Approximately 150 million individuals face catastrophic expenditure each year from medical costs alone, and many more from the nonmedical costs of accessing care. The proportion of this expenditure arising from surgical conditions is unknown. Because World Bank has proposed eliminating medical impoverishment by 2030, the impact of surgical conditions on financial catastrophe must be quantified so that any financial risk protection mechanisms can appropriately incorporate surgery. To determine the global incidence of catastrophic expenditure due to surgery, a stochastic model was built. The income distribution of each country, the probability of requiring surgery, and the medical and nonmedical costs faced for surgery were incorporated. Sensitivity analyses were run to test model robustness. 3.7 billion people risk catastrophic expenditure if they need surgery. Every year, 33 million of them are driven to financial catastrophe from the costs of surgery alone, and 48 million from nonmedical costs, leading to 81 million cases worldwide. The burden of catastrophic expenditure is highest in low- and middle-income countries; within any country, it falls on the poor. Estimates are sensitive to the definition of catastrophic expenditure and the costs of care. The inequitable burden distribution is robust to model assumptions. Half the global population is at risk of financial catastrophe from surgery. Annually, 81 million individuals, especially the poor, face catastrophic expenditure due to surgical conditions, of which less than half is attributable to medical costs. These findings highlight the need for financial risk protection for surgery in health system design. Partial funding for Dr. Shrime from NIH/NCI R25CA92203.